Remodeling

Citations 381-390 of 507 total displayed.

Past content (since Mar 1999):

Scientific Contributions, Part 2
Elastase-Induced Suppression of Endothelin-Mediated Ca²⁺ Entry Mechanisms of Vascular Contraction

David K.W. Chew, Julia M. Orshal, and Raouf A. Khalil
Hypertension 2003;42:818-824; published online before print as doi:10.1161/01.HYP.0000086200.93184.8E [Abstract] [Full text]  

Scientific Contributions
Relation Between Left Ventricular Midwall Function and Coronary Vasodilator Capacity in Arterial Hypertension

Michaela Kozàkovà, Ele Ferrannini, and Carlo Palombo
Hypertension published September 2, 2003, doi:10.1161/01.HYP.0000090120.22445.B0 [Abstract]  

Scientific Contributions
Catecholamines Block the Antimitogenic Effect of Estradiol on Human Glomerular Mesangial Cells

Raghvendra K. Dubey, Lefteris C. Zacharia, Delbert G. Gillespie, Bruno Imthurn, and Edwin K. Jackson
Hypertension 2003;42:349-355; published online before print as doi:10.1161/01.HYP.0000088320.81260.26 [Abstract] [Full text]  

Scientific Contributions
Catecholamines Block the Antimitogenic Effect of Estradiol on Human Glomerular Mesangial Cells

Raghvendra K. Dubey, Lefteris C. Zacharia, Delbert G. Gillespie, Bruno Imthurn, and Edwin K. Jackson
Hypertension published August 11, 2003, doi:10.1161/01.HYP.0000088320.81260.26 [Abstract]  

Scientific Contributions
Elastase-Induced Suppression of Endothelin-Mediated Ca²⁺ Entry Mechanisms of Vascular Contraction

David K.W. Chew, Julia M. Orshal, and Raouf A. Khalil
Hypertension published August 4, 2003, doi:10.1161/01.HYP.0000086200.93184.8E [Abstract]  

Scientific Contributions
Peroxisome Proliferator-Activated Receptor- and Receptor- Activators Prevent Cardiac Fibrosis in Mineralocorticoid-Dependent Hypertension

Marc Iglarz, Rhian M. Touyz, Emilie C. Viel, Pierre Paradis, Farhad Amiri, Quy N. Diep, and Ernesto L. Schiffrin
Hypertension published July 14, 2003, doi:10.1161/01.HYP.0000083511.91817.B1 [Abstract]  

Scientific Contributions
Symptomatic Aortic Stenosis: Does Systemic Hypertension Play an Additional Role?

Francesco Antonini-Canterin, Guoqian Huang, Eugenio Cervesato, Pompilio Faggiano, Daniela Pavan, Rita Piazza, and Gian Luigi Nicolosi
Hypertension 2003;41:1268-1272; published online before print as doi:10.1161/01.HYP.0000070029.30058.59 [Abstract] [Full text]  

Scientific Contributions
Subcellular Redistribution of Focal Adhesion Kinase and Its Related Nonkinase in Hypertrophic Myocardium

Xian Ping Yi, Xuejun Wang, A. Martin Gerdes, and Faqian Li
Hypertension 2003;41:1317-1323; published online before print as doi:10.1161/01.HYP.0000072772.74183.5F [Abstract] [Full text]  

Scientific Contributions
Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na⁺/H⁺ Exchanger Inhibition

Irene L. Ennis, Eduardo M. Escudero, Gloria M. Console, Gisela Camihort, César Gomez Dumm, Randolph W. Seidler, María C. Camilión de Hurtado, and Horacio E. Cingolani
Hypertension 2003;41:1324-1329; published online before print as doi:10.1161/01.HYP.0000071180.12012.6E [Abstract] [Full text]  

Scientific Contributions
AT₁ Receptor Blockade Improves Vasorelaxation in Experimental Renal Failure

Peeter Kööbi, Jarkko Kalliovalkama, Pasi Jolma, Jaana Rysä, Heikki Ruskoaho, Olli Vuolteenaho, Mika Kähönen, Ilkka Tikkanen, Meng Fan, Pauli Ylitalo, and Ilkka Pörsti
Hypertension 2003;41:1364-1371; published online before print as doi:10.1161/01.HYP.0000073782.30879.16 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51